NewsRx

Search our medical news database

Cell Therapy

ThermoGenesis Announces Record Revenues and Key Executive Changes

Published in Medical Patent Business Week, May 11th, 2007

ThermoGenesis Corp. (KOOL) announced it achieved record revenues, exceeding $5 million, for its third fiscal quarter ended March 31, 2007, and key executive management change to support the Company's strategy to accelerate penetration into the high-growth stem cell therapy and surgical wound care markets. Specifically, the Company announced that Chief Executive Officer (CEO) Philip H. Coelho has signed a new employment agreement to become Chief Technology Architect upon the appointment of a new CEO by the Company's Board of Directors, a search for which is underway. Mr. Coelho will remain as Chairman of the Board and continue to serve as CEO until a new CEO is appointed, at which point he...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook